Journals / Turkish Journal of Hematology / 2009 / Cilt: 26 - Sayı: 4

Kırım-Kongo kanamalı ateşinin hematolojik yönleri

Hematological aspects of Crimean-Congo hemorrhagic fever

Pages
161–166
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, recent literature on CCHF has been reviewed, with particular emphasis on hematological manifestations, pathogenesis and therapeutic approaches in CCHF from the hematologist’s point of view.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne viral disease transmitted to humans by Hyalomma ticks or by direct contact with the blood of infected humans or domestic animals.
📊
Key Findings & Data:During the last six- year period from 2003 to 2009, CCHF has also occurred endemically in Turkey, particularly during spring and summer, with a case-fatality rate of approximately 5%.
💡
Conclusion & Impact:In this article, recent literature on CCHF has been reviewed, with particular emphasis on hematological manifestations, pathogenesis and therapeutic approaches in CCHF from the hematologist’s point of view.
🔬Design:Review & Systematic Survey
📍Scope:2003 Verileri
⚙️Variables:Polimeraz zincir reaksiyonu · Erken tanı · Enzim bağlı immünosorbent tayini

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne viral disease transmitted to humans by Hyalomma ticks or by direct contact with the blood of infected humans or domestic animals. In certain areas of the world, including Africa, Asia, South East Europe and Middle East, sporadic cases or outbreaks of CCHF have been reported. During the last six- year period from 2003 to 2009, CCHF has also occurred endemically in Turkey, particularly during spring and summer, with a case-fatality rate of approximately 5%. The disease is characterized by acute fever, nausea, vomiting, headache, myalgia, elevated liver enzymes and hemorrhagic manifestations ranging from mucocutaneous bleeding to life-threatening massive hemorrhage with disseminated intravascular coagulation (DIC) and hemophagocytosis. As with other viral hemorrhagic diseases, activation of lymphocytes, monocytes, macrophages and oversecretion of cytokines play a pivotal role in the pathogenesis and prognosis of CCHF. Recently an increasing number of publications on CCHF have been emerging in the literature, majority of which have been written by infection specialists. In this article, recent literature on CCHF has been reviewed, with particular emphasis on hematological manifestations, pathogenesis and therapeutic approaches in CCHF from the hematologist’s point of view.

Özet

Kırım-Kongo kanamalı ateşi (KKKA) insanlara Hiyalom keneleri aracılığıyla ya da enfekte veya evcil hayvanların kanlarına doğrudan temas aracılığıyla insanlara geçen akut bir kene yoluyla bulaşan viral hastalıktır. Afrika, Asya, Güney Doğu Avrupa ve Orta Doğu da dahil dünyanın belirli bölgelerinde KKKA’ya ait sporadik vakalar yada salgınlar rapor edilmiştir. 2003’ten 2009 yılına kadar geçen altı yıllık süre boyunca özellikle bahar ve yaz aylarında yaklaşık %5’lik bir vaka-ölüm oranıyla endemik olarak Türkiye'de de görülmüştür. Hastalık akut ateş, bulantı, kusma, baş ağrısı, miyalji, karaciğer enzimlerinin yükselmesi ve mukokütanöz kanamadan yaşamı tehdit eden yaygın damariçi intravasküler koagülasyon (DIC) ve hemofa- gositozla birlikte masif kanamalara kadar bir yelpazede hemorajik manifestasyonlar ile karakterizedir. Diğer viral hemorajik hastalıklarda olduğu gibi, lenfositlerin, monositlerin, makrofajların aktivasyonu ve sitokinlerin aşırı sekresyonu KKKA’nın patojenez ve prognozunda kilit bir rol oynar. Son zamanlarda literatürde KKKA ile ilgili olarak daha çok enfeksiyon uzmanları tarafından yazılan yayınlarda artma olduğu görülmektedir. Bu makalede hematologun bakış açısıyla özellikle KKKA’daki hematolojik belirtiler, patojenez ve tedavi yaklaşımları üzerine vurgu yapılarak KKKA hakkında yayınlar gözden geçirilmiştir.

🔖

Cite This Article

DURU, F., FIŞGIN, T. (2009). Kırım-Kongo kanamalı ateşinin hematolojik yönleri. Turkish Journal of Hematology, Cilt: 26 - Sayı: 4, 161–166. https://ajindex.com/articles/413371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ergonul O. Treatment of Crimean Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA, editors. Crimean Congo Hemorrhagic Fever: A Global Perspective. Dordrecht, Netherlands: Springer, 2007: 245-60
  2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145-60
  3. Ergönül O, Zeller H, Kiliç S, Kutlu S, Kutlu M, Cavusoglu S, Esen B, Dokuzoğuz B. Zoonotic infections among veterinarians in Turkey: Crimean-Congo hemorrhagic fever and beyond. Int J.Infect Dis 2006;10:465-9
  4. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia, Europe and Africa. J Med Entomol 1979;15:307-417
  5. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 2007;20:495-500
  6. Ergonul O. Crimean-Congo hemorrhagic fever. Lancet Infect Dis 2006;6:203-6
  7. Schwarz TF, Nsanze A, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 1997;40:364-7
  8. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey: 2002-2007. Int J Infect Dis 2009;13:380-6
  9. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Ozkaya S, Ertek M. A preliminary method on Crimean Congo hemorrhagic fever Turkey, March - June 2008. Euro Surveill 2008;13:18953
  10. Turkish Ministry of Health (Internet). Kırım-kongo kanamalı ateşi vaka ve ölümlerinin yıllara göre dağılımı. Two pages. [updated 2008] Available from: http://www.saglik.gov.tr/KKKA/ BelgeGoster.aspx?F6E10F8892433CFF1A9547B61DAFFE2AA E52736517C4A993 11. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006;52:207-15
  11. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE, Ksiazek TG. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004;10:1379-84
  12. Midilli K, Gargili A, Ergonul O, Sengöz G, Ozturk R, Bakar M, Jongejan F. Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis 2007;7:54
  13. Tasdelen Fisgin N, Tanyel E, Sarikaya H, Cicek B, Doganci L, Tulek N. Kirim Kongo Kanamali ateşi: Endemik bölgedeki üniversite hastanesi deneyimi. Türk Mikrobiyoloji Kongresi, Bodrum, 2008
  14. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Chara